Skip to content
No picture yet

Giotrif 30 mg – DIN 02415674

Giotrif is Afatinib Dimaleate 30 mg (tablet), sold in Canada. It is used for lung cancer and squamous cell carcinoma. It is supplied by Boehringer Ingelheim (Canada) Ltd Ltee. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Afatinib Dimaleate 30 mg

Brand
Giotrif
Strength
30 mg
Used for
Lung cancer and squamous cell carcinoma
Form
Tablet
Manufacturer
Boehringer Ingelheim (Canada) Ltd Ltee
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02415674

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Afatinib Dimaleate pills and guides

What is Afatinib Dimaleate used for?

Afatinib Dimaleate is used for lung cancer and squamous cell carcinoma.

Medicine type
Cancer medicine (kinase inhibitor)

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02415674.
  • It names Giotrif, Afatinib Dimaleate 30 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Giotrif by Boehringer Ingelheim (Canada) Ltd Ltee.

In Canada: prescription only.

Ingredients

Active: Afatinib (Afatinib Dimaleate)

Other Afatinib Dimaleate pills